303 related articles for article (PubMed ID: 12954813)
1. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
2. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
3. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone.
Alencar JL; Lobysheva I; Geffard M; Sarr M; Schott C; Schini-Kerth VB; Nepveu F; Stoclet JC; Muller B
Mol Pharmacol; 2003 May; 63(5):1148-58. PubMed ID: 12695543
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
5. The effects of thiol modulators on nitrergic nerve- and S-nitrosothiols-induced relaxation in duodenum.
Kıroğlu OE; Aydinoglu F; Oğülener N
J Basic Clin Physiol Pharmacol; 2013; 24(2):143-50. PubMed ID: 23412870
[TBL] [Abstract][Full Text] [Related]
6. Extracellular S-nitrosoglutathione, but not S-nitrosocysteine or N(2)O(3), mediates protein S-nitrosation in rat spinal cord slices.
Romero JM; Bizzozero OA
J Neurochem; 2006 Nov; 99(4):1299-310. PubMed ID: 17018024
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation.
Alencar JL; Chalupsky K; Sarr M; Schini-Kerth V; Vanin AF; Stoclet JC; Muller B
Biochem Pharmacol; 2003 Dec; 66(12):2365-74. PubMed ID: 14637194
[TBL] [Abstract][Full Text] [Related]
8. The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione.
Sarr M; Sar FB; Gueye L; Kane MO; Wele A; Diallo AS; Schini-Kerth V; Muller B
Cardiovasc J Afr; 2011; 22(1):7-13. PubMed ID: 21298199
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
[TBL] [Abstract][Full Text] [Related]
11. Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction.
Sarr M; Chataigneau M; Etienne-Selloum N; Diallo AS; Schott C; Geffard M; Stoclet JC; Schini-Kerth VB; Muller B
Nitric Oxide; 2007 Aug; 17(1):1-9. PubMed ID: 17566772
[TBL] [Abstract][Full Text] [Related]
12. The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP.
Kumari S; Sammut IA; Giles GI
Eur J Pharmacol; 2014 Aug; 737():168-76. PubMed ID: 24858367
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.
Müller-Strahl G; Kottenberg K; Zimmer HG; Noack E; Kojda G
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):311-20. PubMed ID: 10639106
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction.
Perrin-Sarrado C; Zhou Y; Salgues V; Parent M; Giummelly P; Lartaud I; Gaucher C
Biochem Pharmacol; 2020 Mar; 173():113686. PubMed ID: 31678494
[TBL] [Abstract][Full Text] [Related]
15. Modification of tubulin cysteines by nitric oxide and nitroxyl donors alters tubulin polymerization activity.
Landino LM; Koumas MT; Mason CE; Alston JA
Chem Res Toxicol; 2007 Nov; 20(11):1693-700. PubMed ID: 17907787
[TBL] [Abstract][Full Text] [Related]
16. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
17. S,S'-dinitrosobucillamine, a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols.
Dahboul F; Perrin-Sarrado C; Boudier A; Lartaud I; Schneider R; Leroy P
Eur J Pharmacol; 2014 May; 730():171-9. PubMed ID: 24625595
[TBL] [Abstract][Full Text] [Related]
18. H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells.
Ondrias K; Stasko A; Cacanyiova S; Sulova Z; Krizanova O; Kristek F; Malekova L; Knezl V; Breier A
Pflugers Arch; 2008 Nov; 457(2):271-9. PubMed ID: 18458940
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats.
McGrowder D; Ragoobirsingh D; Brown P
Med Sci Monit; 2006 Jan; 12(1):BR28-35. PubMed ID: 16369460
[TBL] [Abstract][Full Text] [Related]
20. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
